Duration of anticoagulant therapy for venous thromboembolism: Balancing benefits and harms on the long term

British Journal of Haematology

Volumn 158, Issue 4, 2012, Pages 433-441

  de Jong, Paulien G ^a   Coppens, Michiel ^a,b   Middeldorp, Saskia ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Anticoagulant therapy; Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; CLOPIDOGREL; D DIMER; DABIGATRAN; ESTROGEN; LOW MOLECULAR WEIGHT HEPARIN; ORAL CONTRACEPTIVE AGENT; RIVAROXABAN;

AGE DISTRIBUTION; AGING; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; BLEEDING; COMPRESSION GARMENT; CROHN DISEASE; DRUG EFFICACY; DRUG WITHDRAWAL; GENETIC DISORDER; HORMONE SUBSTITUTION; HUMAN; INFLAMMATORY DISEASE; LONG TERM CARE; MALIGNANT NEOPLASTIC DISEASE; OBESITY; POSTTHROMBOSIS SYNDROME; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RECURRENT DISEASE; REVIEW; RISK FACTOR; SEX DIFFERENCE; STROKE; SURGICAL RISK; THROMBOPHILIA; THROMBOSIS; TREATMENT DURATION; ULCERATIVE COLITIS; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; HEMORRHAGE; HUMANS; RECURRENCE; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

EID: 84864325727     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09196.x     Document Type: Review

References (82)

1. Ageno, W., Gallus, A.S., Wittkowsky, A., Crowther, M., Hylek, E.M. & Palareti, G. (2012) Oral anticoagulant therapy: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e44S-e88S.
2. Anderson, Jr, F.A., Wheeler, H.B., Goldberg, R.J., Hosmer, D.W., Patwardhan, N.A., Jovanovic, B., Forcier, A. & Dalen, J.E. (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Archives of Internal Medicine, 151, 933-938.
3. Badaracco, M.A. & Vessey, M.P. (1974) Recurrence of venous thromboembolic disease and use of oral contraceptives. British Medical Journal, 1, 215-217.
4. Baglin, T., Luddington, R., Brown, K. & Baglin, C. (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet, 362, 523-526.
5. Baglin, T., Douketis, J., Tosetto, A., Marcucci, M., Cushman, M., Kyrle, P., Palareti, G., Poli, D., Tait, R.C. & Iorio, A. (2010) Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. Journal of Thrombosis and Haemostasis, 8, 2436-2442.
6. Baglin, T., Bauer, K., Douketis, J., Buller, H., Srivastava, A. & Johnson, G. (2012) Duration of anticoagulant therapy after a first episode of unprovoked pulmonary embolus or deep vein thrombosis: guidance from the scientific and standardization committee of the international society on thrombosis and haemostasis. Journal of Thrombosis and Haemostasis, 10, 698-702.
7. Bates, S.M., Greer, I.A., Middeldorp, S., Veenstra, D.L., Prabulos, A.M. & Vandvik, P.O. (2012) VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e691S-e736S.
8. Bauersachs, R., Berkowitz, S.D., Brenner, B., Buller, H.R., Decousus, H., Gallus, A.S., Lensing, A.W., Misselwitz, F., Prins, M.H., Raskob, G.E., Segers, A., Verhamme, P., Wells, P., Agnelli, G., Bounameaux, H., Cohen, A., Davidson, B.L., Piovella, F. & Schellong, S. (2010) Oral rivaroxaban for symptomatic venous thromboembolism. New England Journal of Medicine, 363, 2499-2510.
9. Bernstein, C.N., Blanchard, J.F., Houston, D.S. & Wajda, A. (2001) The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thrombosis and Haemostasis, 85, 430-434.
10. Boutitie, F., Pinede, L., Schulman, S., Agnelli, G., Raskob, G., Julian, J., Hirsh, J. & Kearon, C. (2011) Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials. British Medical Journal, 342, d3036.
11. Brandjes, D.P., Buller, H.R., Heijboer, H., Huisman, M.V., de, R.M., Jagt, H. & ten Cate, J.W. (1997) Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet, 349, 759-762.
12. Canonico, M., Plu-Bureau, G., Lowe, G.D. & Scarabin, P.Y. (2008) Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. British Medical Journal, 336, 1227-1231.
13. Carrier, M., Le Gal, G., Wells, P.S. & Rodger, M.A. (2010) Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Annals of Internal Medicine, 152, 578-589.
14. Carrier, M., Rodger, M.A., Wells, P.S., Righini, M. & Le Gal, G. (2011) Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis, 9, 1119-1125.
15. Christiansen, S.C., Cannegieter, S.C., Koster, T., Vandenbroucke, J.P. & Rosendaal, F.R. (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. Journal of the American Medical Association, 293, 2352-2361.
16. Connolly, S.J., Ezekowitz, M.D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P.A., Themeles, E., Varrone, J., Wang, S., Alings, M., Xavier, D., Zhu, J., Diaz, R., Lewis, B.S., Darius, H., Diener, H.C., Joyner, C.D. & Wallentin, L. (2009) Dabigatran versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 361, 1139-1151.
17. Cushman, M., Glynn, R.J., Goldhaber, S.Z., Moll, S., Bauer, K.A., Deitcher, S., Shrivastava, S. & Ridker, P.M. (2006) Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. Journal of Thrombosis and Haemostasis, 4, 2199-2203.
18. De Stefano, V., Martinelli, I., Rossi, E., Battaglioli, T., Za, T., Mannuccio, M.P. & Leone, G. (2006) The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. British Journal of Haematology, 135, 386-391.
19. Donadini, M.P. & Ageno, W. (2011) Which patients with unprovoked VTE should receive extended anticoagulation? the minority. Journal of Thrombosis and Thrombolysis, 31, 301-305.
20. van Dongen, C.J., Vink, R., Hutten, B.A., Buller, H.R. & Prins, M.H. (2003) The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis. Archives of Internal Medicine, 163, 1285-1293.
21. Douketis, J.D., Kearon, C., Bates, S., Duku, E.K. & Ginsberg, J.S. (1998) Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. Journal of the American Medical Association, 279, 458-462.
22. Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cosmi, B., Cushman, M., Kyrle, P., Poli, D., Tait, R.C. & Iorio, A. (2011) Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. British Medical Journal, 342, d813.
23. Doyle, D.J., Turpie, A.G., Hirsh, J., Best, C., Kinch, D., Levine, M.N. & Gent, M. (1987) Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial. Annals of Internal Medicine, 107, 441-445.
24. Farmer, R.D., Lawrenson, R.A., Thompson, C.R., Kennedy, J.G. & Hambleton, I.R. (1997) Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet, 349, 83-88.
25. Farraj, R.S. (2004) Anticoagulation period in idiopathic venous thromboembolism. How long is enough? Saudi Medical Journal, 25, 848-851.
26. Flinterman, L.E., van Hylckama Vlieg, A., Rosendaal, F.R. & Doggen, C.J. (2008) Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity. Circulation, 118, 1366-1372.
27. Guyatt, G.H., Norris, S.L., Schulman, S., Hirsh, J., Eckman, M.H., Akl, E.A., Crowther, M., Vandvik, P.O., Eikelboom, J.W., McDonagh, M.S., Lewis, S.Z., Gutterman, D.D., Cook, D.J. & Schunemann, H.J. (2012) Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, 53S-70S.
28. Hart, R.G., Benavente, O. & Pearce, L.A. (1999) Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: a meta-analysis and hypothesis. Cerebrovascular Diseases, 9, 215-217.
29. Heit, J.A., Silverstein, M.D., Mohr, D.N., Petterson, T.M., O'Fallon, W.M. & Melton, L.J. III (2000a) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Archives of Internal Medicine, 160, 809-815.
30. Heit, J.A., Mohr, D.N., Silverstein, M.D., Petterson, T.M., O'Fallon, W.M. & Melton, L.J. III (2000b) Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Archives of Internal Medicine, 160, 761-768.
31. Ho, W.K., Hankey, G.J., Quinlan, D.J. & Eikelboom, J.W. (2006) Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Archives of Internal Medicine, 166, 729-736.
32. Huisman, M.V., Buller, H.R., ten Cate, J.W., van Royen, E.A., Vreeken, J., Kersten, M.J. & Bakx, B. (1989) Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest, 95, 498-502.
33. Hull, R.D., Hirsh, J., Carter, C.J., Jay, R.M., Dodd, P.E., Ockelford, P.A., Coates, G., Gill, G.J., Turpie, A.G., Doyle, D.J., Buller, H.R. & Raskob, G.E. (1983) Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Annals of Internal Medicine, 98, 891-899.
34. Hutten, B.A. & Prins, M.H. (2006) Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism. Cochrane Database of Systematic Reviews, issue 1, Art. No CD001367.
35. Hutten, B.A., Lensing, A.W., Kraaijenhagen, R.A. & Prins, M.H. (1999) Safety of treatment with oral anticoagulants in the elderly. A systematic review. Drugs and Aging, 14, 303-312.
36. van Hylckama Vlieg, A. & Middeldorp, S. (2011) Hormone therapies and venous thromboembolism: where are we now? Journal of Thrombosis and Haemostasis, 9, 257-266.
37. van Hylckama Vlieg, A., Helmerhorst, F.M., Vandenbroucke, J.P., Doggen, C.J. & Rosendaal, F.R. (2009) The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. British Medical Journal, 339, b2921.
38. Iorio, A., Kearon, C., Filippucci, E., Marcucci, M., Macura, A., Pengo, V., Siragusa, S. & Palareti, G. (2010) Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. Archives of Internal Medicine, 170, 1710-1716.
39. Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M.J., Anderson, D.R., Turpie, A.G., Green, D., Ginsberg, J.S., Wells, P., MacKinnon, B. & Julian, J.A. (1999) A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine, 340, 901-907.
40. Kearon, C., Akl, E.A., Comerota, A.J., Prandoni, P., Bounameaux, H., Goldhaber, S.Z., Nelson, M.E., Wells, P.S., Gould, M.K., Dentali, F., Crowther, M. & Kahn, S.R. (2012) Antithrombotic therapy for VTE disease: antithrombotic Therapy and Prevention of Thrombosis, 9th edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e419S-e494S.
41. Kruit, W.H., de Boer, A.C., Sing, A.K. & van Roon, F. (1991) The significance of venography in the management of patients with clinically suspected pulmonary embolism. Journal of Internal Medicine, 230, 333-339.
42. Kyrle, P.A., Minar, E., Bialonczyk, C., Hirschl, M., Weltermann, A. & Eichinger, S. (2004) The risk of recurrent venous thromboembolism in men and women. New England Journal of Medicine, 350, 2558-2563.
43. Le Gal, G., Kovacs, M.J., Carrier, M., Do, K., Kahn, S.R., Wells, P.S., Anderson, D.A., Chagnon, I., Solymoss, S., Crowther, M., Righini, M., Lacut, K., White, R.H., Vickars, L. & Rodger, M. (2010) Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study. Thrombosis and Haemostasis, 104, 498-503.
44. Lee, A.Y., Levine, M.N., Baker, R.I., Bowden, C., Kakkar, A.K., Prins, M., Rickles, F.R., Julian, J.A., Haley, S., Kovacs, M.J. & Gent, M. (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. New England Journal of Medicine, 349, 146-153.
45. Lidegaard, O., Lokkegaard, E., Svendsen, A.L. & Agger, C. (2009) Hormonal contraception and risk of venous thromboembolism: national follow-up study. British Medical Journal, 339, b2890.
46. Lijfering, W.M., Veeger, N.J., Middeldorp, S., Hamulyak, K., Prins, M.H., Buller, H.R. & Van Der Meer, J. (2009) A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families. Blood, 114, 2031-2036.
47. Lim, W., Crowther, M.A. & Eikelboom, J.W. (2006) Management of antiphospholipid antibody syndrome: a systematic review. Journal of the American Medical Association, 295, 1050-1057.
48. Linkins, L.A., Choi, P.T. & Douketis, J.D. (2003) Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Annals of Internal Medicine, 139, 893-900.
49. Locadia, M., Bossuyt, P.M., Stalmeier, P.F., Sprangers, M.A., van Dongen, C.J., Middeldorp, S., Bank, I., Van Der Meer, J., Hamulyak, K. & Prins, M.H. (2004) Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences. Thrombosis and Haemostasis, 92, 1336-1341.
50. Martinelli, I., Battaglioli, T., Bucciarelli, P., Passamonti, S.M. & Mannucci, P.M. (2004) Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Circulation, 110, 566-570.
51. McRae, S., Tran, H., Schulman, S., Ginsberg, J. & Kearon, C. (2006) Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet, 368, 371-378.
52. van der Meer, F.J., Rosendaal, F.R., Vandenbroucke, J.P. & Briet, E. (1993) Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Archives of Internal Medicine, 153, 1557-1562.
53. van der Meer, F.J., Rosendaal, F.R., Vandenbroucke, J.P. & Briet, E. (1996) Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants. Thrombosis and Haemostasis, 76, 12-16.
54. Middeldorp, S. (2011a) Is thrombophilia testing useful? American Society of Hematology Education Program, 2011, 150-155.
55. Middeldorp, S. (2011b) Duration of anticoagulation for venous thromboembolism. British Medical Journal, 342, d2758.
56. Miehsler, W., Reinisch, W., Valic, E., Osterode, W., Tillinger, W., Feichtenschlager, T., Grisar, J., Machold, K., Scholz, S., Vogelsang, H. & Novacek, G. (2004) Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut, 53, 542-548.
57. Murin, S., Romano, P.S. & White, R.H. (2002) Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thrombosis and Haemostasis, 88, 407-414.
58. Naess, I.A., Christiansen, S.C., Romundstad, P., Cannegieter, S.C., Rosendaal, F.R. & Hammerstrom, J. (2007) Incidence and mortality of venous thrombosis: a population-based study. Journal of Thrombosis and Haemostasis, 5, 692-699.
59. Novacek, G., Weltermann, A., Sobala, A., Tilg, H., Petritsch, W., Reinisch, W., Mayer, A., Haas, T., Kaser, A., Feichtenschlager, T., Fuchssteiner, H., Knoflach, P., Vogelsang, H., Miehsler, W., Platzer, R., Tillinger, W., Jaritz, B., Schmid, A., Blaha, B., Dejaco, C. & Eichinger, S. (2010) Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology, 139, 779-787.
60. Pabinger, I., Grafenhofer, H., Kyrle, P.A., Quehenberger, P., Mannhalter, C., Lechner, K. & Kaider, A. (2002) Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood, 100, 1060-1062.
61. Pabinger, I., Grafenhofer, H., Kaider, A., Kyrle, P.A., Quehenberger, P., Mannhalter, C. & Lechner, K. (2005) Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. Journal of Thrombosis and Haemostasis, 3, 949-954.
62. Palareti, G., Legnani, C., Cosmi, B., Guazzaloca, G., Pancani, C. & Coccheri, S. (2002) Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thrombosis and Haemostasis, 87, 7-12.
63. Palareti, G., Cosmi, B., Legnani, C., Tosetto, A., Brusi, C., Iorio, A., Pengo, V., Ghirarduzzi, A., Pattacini, C., Testa, S., Lensing, A.W. & Tripodi, A. (2006) D-dimer testing to determine the duration of anticoagulation therapy. New England Journal of Medicine, 355, 1780-1789.
64. Patel, M.R., Mahaffey, K.W., Garg, J., Pan, G., Singer, D.E., Hacke, W., Breithardt, G., Halperin, J.L., Hankey, G.J., Piccini, J.P., Becker, R.C., Nessel, C.C., Paolini, J.F., Berkowitz, S.D., Fox, K.A. & Califf, R.M. (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New England Journal of Medicine, 365, 883-891.
65. Pomp, E.R., le Cessie, S., Rosendaal, F.R. & Doggen, C.J. (2007) Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. British Journal of Haematology, 139, 289-296.
66. Pomp, E.R., Lenselink, A.M., Rosendaal, F.R. & Doggen, C.J. (2008) Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. Journal of Thrombosis and Haemostasis, 6, 632-637.
67. Prandoni, P., Lensing, A.W., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A.M., Polistena, P., Bernardi, E. & Prins, M.H. (1996) The long-term clinical course of acute deep venous thrombosis. Annals of Internal Medicine, 125, 1-7.
68. Prandoni, P., Lensing, A.W., Piccioli, A., Bernardi, E., Simioni, P., Girolami, B., Marchiori, A., Sabbion, P., Prins, M.H., Noventa, F. & Girolami, A. (2002a) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood, 100, 3484-3488.
69. Prandoni, P., Lensing, A.W., Prins, M.H., Bernardi, E., Marchiori, A., Bagatella, P., Frulla, M., Mosena, L., Tormene, D., Piccioli, A., Simioni, P. & Girolami, A. (2002b) Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Annals of Internal Medicine, 137, 955-960.
70. Prandoni, P., Lensing, A.W., Prins, M.H., Frulla, M., Marchiori, A., Bernardi, E., Tormene, D., Mosena, L., Pagnan, A. & Girolami, A. (2004) Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Annals of Internal Medicine, 141, 249-256.
71. Prandoni, P., Noventa, F., Ghirarduzzi, A., Pengo, V., Bernardi, E., Pesavento, R., Iotti, M., Tormene, D., Simioni, P. & Pagnan, A. (2007) The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1, 626 patients. Haematologica, 92, 199-205.
72. Ridker, P.M., Goldhaber, S.Z., Danielson, E., Rosenberg, Y., Eby, C.S., Deitcher, S.R., Cushman, M., Moll, S., Kessler, C.M., Elliott, C.G., Paulson, R., Wong, T., Bauer, K.A., Schwartz, B.A., Miletich, J.P., Bounameaux, H. & Glynn, R.J. (2003) Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine, 348, 1425-1434.
73. Rodger, M.A., Kahn, S.R., Wells, P.S., Anderson, D.A., Chagnon, I., Le Gal, G., Solymoss, S., Crowther, M., Perrier, A., White, R., Vickars, L., Ramsay, T., Betancourt, M.T. & Kovacs, M.J. (2008) Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. Canadian Medical Association Journal, 179, 417-426.
74. Schulman, S., Granqvist, S., Holmstrom, M., Carlsson, A., Lindmarker, P., Nicol, P., Eklund, S.G., Nordlander, S., Larfars, G., Leijd, B., Linder, O. & Loogna, E. (1997) The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. New England Journal of Medicine, 336, 393-398.
75. Schulman, S., Svenungsson, E. & Granqvist, S. (1998) Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. American Journal of Medicine, 104, 332-338.
76. Schulman, S., Wahlander, K., Lundstrom, T., Clason, S.B. & Eriksson, H. (2003) Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. New England Journal of Medicine, 349, 1713-1721.
77. Schulman, S., Kearon, C., Kakkar, A.K., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J. & Goldhaber, S.Z. (2009) Dabigatran versus warfarin in the treatment of acute venous thromboembolism. New England Journal of Medicine, 361, 2342-2352.
78. Schulman, S., Baanstra, D., Eriksson, H., Goldhaber, S., Kakkar, A., Kearon, C., Mismetti, P., Schellong, S. & Schnee, J. (2011) Dabigatran versus placebo for extended maintenance therapy of venous thromboembolism. Journal of Thrombosis and Haemostasis, 9, 1-250. O-MO-037.
79. Stain, M., Schonauer, V., Minar, E., Bialonczyk, C., Hirschl, M., Weltermann, A., Kyrle, P.A. & Eichinger, S. (2005) The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. Journal of Thrombosis and Haemostasis, 3, 2671-2676.
80. Verhovsek, M., Douketis, J.D., Yi, Q., Shrivastava, S., Tait, R.C., Baglin, T., Poli, D. & Lim, W. (2008) Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Annals of Internal Medicine, 149, 481-490, W94.
81. White, R.H., Chan, W.S., Zhou, H. & Ginsberg, J.S. (2008) Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism. Thrombosis and Haemostasis, 100, 246-252.
82. Zoller, B., Li, X., Sundquist, J. & Sundquist, K. (2012) Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet, 379, 244-249.